Literature DB >> 22877868

Decaffeinated green tea extract improves hypertension and insulin resistance in a rat model of metabolic syndrome.

Sang-Hyun Ihm1, Sung-Won Jang, Ok-Ran Kim, Kiyuk Chang, Min-Ho Oak, Jung-Ok Lee, Dong-Yoon Lim, Jae-Hyung Kim.   

Abstract

BACKGROUND: Oxidative stress and endothelial dysfunction are closely associated with hypertension and insulin resistance (IR) in metabolic syndrome (MetS). It is still controversial whether green tea extract (GTE) may have blood pressure (BP) lowering effect. Decaffeinated GTE might be presumed to have strong antioxidative effect and BP-lowering effect as compared with catechins. Thus we investigated whether decaffeinated-GTE could attenuate hypertension and IR by improving endothelial dysfunction and reducing oxidative stress in a rat model of MetS. METHODS AND
RESULTS: 20 Otsuka Long-Evans Tokushima Fatty (OLETF) rats at 13 weeks old, MetS rats, were randomized into a saline treated group (OLETF; n = 10) and a group treated with decaffeinated-GTE (25 mg/kg/day) (GTE-OLETF; n = 10). Intraperitoneal glucose tolerance tests and BP measurements were performed at 13 and 25 weeks. Decaffeinated-GTE significantly reduced BP (OLETF vs. GTE-OLETF; 130 ± 7 vs. 121 ± 3 mmHg, p = 0.01), fasting/postprandial 2 h glucose (141 ± 18/159 ± 13 vs. 115 ± 7/132 ± 16 mg/dL, p = 0.009/0.002) and insulin levels (4.8 ± 2.3 vs. 2.4 ± 1.3 ng/mL, p < 0.001). Decaffeinated-GTE significantly reduced vascular reactive oxygen species (ROS) formation and NADPH oxidase activity, and improved endothelium dependent relaxation in the thoracic aorta of OLETF rats. Decaffeinated-GTE also suppressed the expression of p47 and p22phox (NADPH oxidase subunits) in the immunohistochemical staining, and stimulated phosphorylation of endothelial nitric oxide synthase (eNOS) and Akt in the immunoblotting of aortas.
CONCLUSIONS: Decaffeinated-GTE reduced the formation of ROS and NADPH oxidase activity and stimulated phosphorylation of eNOS and Akt in the aorta of a rat model of MetS, which resulted in improved endothelial dysfunction and IR, and eventually lowered BP.
Copyright © 2012. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22877868     DOI: 10.1016/j.atherosclerosis.2012.07.006

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  14 in total

Review 1.  Nutraceuticals and Blood Pressure Control: Results from Clinical Trials and Meta-Analyses.

Authors:  Arrigo F G Cicero; Alessandro Colletti
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-03-19

2.  Synergistic effect of herbal plant extract (Hibiscus sabdariffa) in maintain the antioxidant activity of decaffeinated green tea from various parts of Assam.

Authors:  Abhijit Das; Anamika Kalita; Utpal Raychaiudhuri; Runu Chakraborty
Journal:  J Food Sci Technol       Date:  2019-07-30       Impact factor: 2.701

Review 3.  Nutraceuticals with a clinically detectable blood pressure-lowering effect: a review of available randomized clinical trials and their meta-analyses.

Authors:  Claudio Borghi; Arrigo F G Cicero
Journal:  Br J Clin Pharmacol       Date:  2016-03-15       Impact factor: 4.335

4.  Correlation between tea consumption and prevalence of hypertension among Singaporean Chinese residents aged ⩾40 years.

Authors:  W Li; J Yang; X S Zhu; S C Li; P C Ho
Journal:  J Hum Hypertens       Date:  2015-05-28       Impact factor: 3.012

5.  Green and Oolong Tea Extracts With Different Phytochemical Compositions Prevent Hypertension and Modulate the Intestinal Flora in a High-Salt Diet Fed Wistar Rats.

Authors:  Xin Ye; Xiaojuan Tang; Fanglan Li; Jiangxiong Zhu; Meirong Wu; Xinlin Wei; Yuanfeng Wang
Journal:  Front Nutr       Date:  2022-05-06

6.  Asiatic acid alleviates hemodynamic and metabolic alterations via restoring eNOS/iNOS expression, oxidative stress, and inflammation in diet-induced metabolic syndrome rats.

Authors:  Poungrat Pakdeechote; Sarawoot Bunbupha; Upa Kukongviriyapan; Parichat Prachaney; Wilaiwan Khrisanapant; Veerapol Kukongviriyapan
Journal:  Nutrients       Date:  2014-01-16       Impact factor: 5.717

7.  Green tea and one of its constituents, Epigallocatechine-3-gallate, are potent inhibitors of human 11β-hydroxysteroid dehydrogenase type 1.

Authors:  Jan Hintzpeter; Claudia Stapelfeld; Christine Loerz; Hans-Joerg Martin; Edmund Maser
Journal:  PLoS One       Date:  2014-01-03       Impact factor: 3.240

Review 8.  Vascular and metabolic actions of the green tea polyphenol epigallocatechin gallate.

Authors:  Michelle A Keske; Huei L H Ng; Dino Premilovac; Stephen Rattigan; Jeong-A Kim; Kashif Munir; Peixin Yang; Michael J Quon
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

9.  Effects of green tea supplementation on inflammation markers, antioxidant status and blood pressure in NaCl-induced hypertensive rat model.

Authors:  Monika Szulińska; Marta Stępień; Matylda Kręgielska-Narożna; Joanna Suliburska; Damian Skrypnik; Monika Bąk-Sosnowska; Magdalena Kujawska-Łuczak; Małgorzata Grzymisławska; Paweł Bogdański
Journal:  Food Nutr Res       Date:  2017-03-03       Impact factor: 3.894

10.  Effect of green tea supplementation on blood pressure among overweight and obese adults: a protocol for a systematic review.

Authors:  Guowei Li; Yuan Zhang; Lawrence Mbuagbaw; Anne Holbrook; Mitchell A H Levine; Lehana Thabane
Journal:  BMJ Open       Date:  2014-04-17       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.